Literature DB >> 20663873

Regulation of Skp2 levels by the Pim-1 protein kinase.

Bo Cen1, Sandeep Mahajan, Marina Zemskova, Zanna Beharry, Ying-Wei Lin, Scott D Cramer, Michael B Lilly, Andrew S Kraft.   

Abstract

The Pim-1 protein kinase plays an important role in regulating both cell growth and survival and enhancing transformation by multiple oncogenes. The ability of Pim-1 to regulate cell growth is mediated, in part, by the capacity of this protein kinase to control the levels of the p27, a protein that is a critical regulator of cyclin-dependent kinases that mediate cell cycle progression. To understand how Pim-1 is capable of regulating p27 protein levels, we focused our attention on the SCF(Skp2) ubiquitin ligase complex that controls the rate of degradation of this protein. We found that expression of Pim-1 increases the level of Skp2 through direct binding and phosphorylation of multiple sites on this protein. Along with known Skp2 phosphorylation sites including Ser(64) and Ser(72), we have identified Thr(417) as a unique Pim-1 phosphorylation target. Phosphorylation of Thr(417) controls the stability of Skp2 and its ability to degrade p27. Additionally, we found that Pim-1 regulates the anaphase-promoting complex or cyclosome (APC/C complex) that mediates the ubiquitination of Skp2. Pim-1 phosphorylates Cdh1 and impairs binding of this protein to another APC/C complex member, CDC27. These modifications inhibit Skp2 from degradation. Marked increases in Skp2 caused by these mechanisms lower cellular p27 levels. Consistent with these observations, we show that Pim-1 is able to cooperate with Skp2 to signal S phase entry. Our data reveal a novel Pim-1 kinase-dependent signaling pathway that plays a crucial role in cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663873      PMCID: PMC2937943          DOI: 10.1074/jbc.M110.137240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Mitotic regulation of the APC activator proteins CDC20 and CDH1.

Authors:  E R Kramer; N Scheuringer; A V Podtelejnikov; M Mann; J M Peters
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.

Authors:  H Sutterlüty; E Chatelain; A Marti; C Wirbelauer; M Senften; U Müller; W Krek
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

3.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

4.  Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

Authors:  Zuping Xia; Christian Knaak; Jian Ma; Zanna M Beharry; Campbell McInnes; Wenxue Wang; Andrew S Kraft; Charles D Smith
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

5.  Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.

Authors:  Daming Gao; Hiroyuki Inuzuka; Alan Tseng; Rebecca Y Chin; Alex Toker; Wenyi Wei
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

6.  Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.

Authors:  Chunaram Choudhary; Jesper V Olsen; Christian Brandts; Jürgen Cox; Pavankumar N G Reddy; Frank D Böhmer; Volker Gerke; Dirk-E Schmidt-Arras; Wolfgang E Berdel; Carsten Müller-Tidow; Matthias Mann; Hubert Serve
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

7.  Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells.

Authors:  Zanna Beharry; Marina Zemskova; Sandeep Mahajan; Fengxue Zhang; Jian Ma; Zuping Xia; Michael Lilly; Charles D Smith; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

8.  Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src.

Authors:  Bo Cen; Haiyang Li; I Bernard Weinstein
Journal:  J Biol Chem       Date:  2008-12-27       Impact factor: 5.157

9.  Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

Authors:  Corey Speers; Anna Tsimelzon; Krystal Sexton; Ashley M Herrick; Carolina Gutierrez; Aedin Culhane; John Quackenbush; Susan Hilsenbeck; Jenny Chang; Powel Brown
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

10.  Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.

Authors:  Alex N Bullock; Santina Russo; Ann Amos; Nicholas Pagano; Howard Bregman; Judit E Debreczeni; Wen Hwa Lee; Frank von Delft; Eric Meggers; Stefan Knapp
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

View more
  12 in total

Review 1.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

2.  The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.

Authors:  Bo Cen; Ying Xiong; Jin H Song; Sandeep Mahajan; Rachel DuPont; Kristen McEachern; Daniel J DeAngelo; Jorge E Cortes; Mark D Minden; Allen Ebens; Alice Mims; Amanda C LaRue; Andrew S Kraft
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

3.  Cell cycle control in acute myeloid leukemia.

Authors:  Dominik Schnerch; Jasmin Yalcintepe; Andrea Schmidts; Heiko Becker; Marie Follo; Monika Engelhardt; Ralph Wäsch
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

4.  JunD/AP-1-mediated gene expression promotes lymphocyte growth dependent on interleukin-7 signal transduction.

Authors:  Shannon M Ruppert; Mounir Chehtane; Ge Zhang; Haiyan Hu; Xiaoman Li; Annette R Khaled
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

5.  Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.

Authors:  K H Koo; H Kim; Y-K Bae; K Kim; B-K Park; C-H Lee; Y-N Kim
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

6.  EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

Authors:  Shuvomoy Banerjee; Jie Lu; Qiliang Cai; Zhiguo Sun; Hem Chandra Jha; Erle S Robertson
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

7.  Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.

Authors:  Qirong Geng; Jianjun Liu; Zhaohui Gong; Shangxiang Chen; Shuai Chen; Xiaoxing Li; Yue Lu; Xiaofeng Zhu; Hui-Kuan Lin; Dazhi Xu
Journal:  Mol Cancer       Date:  2017-04-26       Impact factor: 27.401

8.  Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.

Authors:  S Kreuz; K B Holmes; R M Tooze; P F Lefevre
Journal:  Mol Cancer       Date:  2015-12-08       Impact factor: 27.401

9.  Insulin receptor substrate 1 is a substrate of the Pim protein kinases.

Authors:  Jin H Song; Sathish K R Padi; Libia A Luevano; Mark D Minden; Daniel J DeAngelo; Gary Hardiman; Lauren E Ball; Noel A Warfel; Andrew S Kraft
Journal:  Oncotarget       Date:  2016-04-12

10.  PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.

Authors:  Neha Singh; Sathish K R Padi; Jeremiah J Bearss; Ritu Pandey; Koichi Okumura; Himisha Beltran; Jin H Song; Andrew S Kraft; Virginie Olive
Journal:  Mol Oncol       Date:  2020-04-01       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.